Buparlisib is a brain penetrable pan-PI3K inhibitor

por de Gooijer, Mark C., Zhang, Ping, Buil, Levi C. M., Çitirikkaya, Ceren H., Thota, Nishita, Beijnen, Jos H., van Tellingen, Olaf
Publicado 2018

ATP-binding cassette transporters restrict drug delivery and efficacy against brain tumors even when blood-brain barrier integrity is lost

por de Gooijer, Mark C., Kemper, E. Marleen, Buil, Levi C.M., Çitirikkaya, Ceren H., Buckle, Tessa, Beijnen, Jos H., van Tellingen, Olaf
Publicado 2021

BCRP drives intrinsic chemoresistance in chemotherapy-naïve breast cancer brain metastasis

por Uceda-Castro, Rebeca, Margarido, Andreia S., Song, Ji-Ying, de Gooijer, Mark C., Messal, Hendrik A., Chambers, Cecilia R., Nobis, Max, Çitirikkaya, Ceren H., Hahn, Kerstin, Seinstra, Danielle, Herrmann, David, Timpson, Paul, Wesseling, Pieter, van Tellingen, Olaf, Vennin, Claire, van Rheenen, Jacco
Publicado 2023

Re-purposing the pro-senescence properties of doxorubicin to introduce immunotherapy in breast cancer brain metastasis

por Uceda-Castro, Rebeca, Margarido, Andreia S., Cornet, Lesley, Vegna, Serena, Hahn, Kerstin, Song, Ji-Ying, Putavet, Diana A., van Geldorp, Mariska, Çitirikkaya, Ceren H., de Keizer, Peter L.J., ter Beek, Leon C., Borst, Gerben R., Akkari, Leila, van Tellingen, Olaf, Broekman, Marike L.D., Vennin, Claire, van Rheenen, Jacco
Publicado 2022